These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 353416)
1. Changes in striatal specific 3-H-atropine binding after unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurones. Kato G; Carson S; Kemel ML; Glowinski J; Giorguieff MF Life Sci; 1978 May; 22(18):1607-14. PubMed ID: 353416 [No Abstract] [Full Text] [Related]
2. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density. Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504 [TBL] [Abstract][Full Text] [Related]
3. Effect of long-term L-dopa administration on the dopaminergic and cholinergic (muscarinic) receptors of striatum in 6-hydroxydopamine lesioned rats. Suga M Life Sci; 1980 Sep; 27(10):877-82. PubMed ID: 7412476 [No Abstract] [Full Text] [Related]
4. The localization of receptor binding sites in the substantia nigra and striatum of the rat. Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532 [TBL] [Abstract][Full Text] [Related]
5. Binding experiments of muscarinic acetylcholine and dopamine receptors in human brains with emphasis on a case of striatonigral degeneration. Shimoyama M; Kito S; Itoga E; Kishida T; Nanba K Jpn J Pharmacol; 1982 Dec; 32(6):1157-66. PubMed ID: 6819376 [TBL] [Abstract][Full Text] [Related]
6. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat. Graham WC; Crossman AR; Woodruff GN Brain Res; 1990 Apr; 514(1):93-102. PubMed ID: 2113410 [TBL] [Abstract][Full Text] [Related]
7. The effects of nigrostriatal 6-hydroxydopamine lesions on dopamine D2 receptor mRNA and opioid systems. Mansour A; Meador-Woodruff JH; Camp DM; Robinson TE; Bunzow J; Van Tol H; Civelli O; Akil H; Watson SJ Prog Clin Biol Res; 1990; 328():227-30. PubMed ID: 2106148 [No Abstract] [Full Text] [Related]
8. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats. Geula C; Slevin JT Synapse; 1989; 4(3):248-53. PubMed ID: 2532792 [TBL] [Abstract][Full Text] [Related]
9. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine. Roger LJ; Breese GR; Morell P Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743 [TBL] [Abstract][Full Text] [Related]
10. Enkephalin receptors on dopaminergic neurones in rat striatum. Pollard H; Llorens-Cortes C; Schwartz JC Nature; 1977 Aug; 268(5622):745-7. PubMed ID: 197427 [No Abstract] [Full Text] [Related]
11. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Clarke PB; Pert A Brain Res; 1985 Dec; 348(2):355-8. PubMed ID: 4075093 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants. Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173 [TBL] [Abstract][Full Text] [Related]
13. Opioid binding sites in the nigrostriatal system of the guinea pig are not located on nigral dopaminergic neurons. Foote RW; Maurer R Neurosci Lett; 1986 Apr; 65(3):341-5. PubMed ID: 3012421 [TBL] [Abstract][Full Text] [Related]
14. 6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors. Porceddu ML; Giorgi O; De Montis G; Mele S; Cocco L; Ongini E; Biggio G Life Sci; 1987 Aug; 41(6):697-706. PubMed ID: 2956472 [TBL] [Abstract][Full Text] [Related]
16. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats. Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269 [TBL] [Abstract][Full Text] [Related]
17. Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat. Savasta M; Dubois A; Benavides J; Scatton B Neurosci Lett; 1986 Dec; 72(3):265-71. PubMed ID: 2950341 [TBL] [Abstract][Full Text] [Related]
18. Dopamine and opiate receptors: localization in the striatum and evidence for their axoplasmic transport in the nigrostriatal and striatonigral pathways. Van der Kooy D; Weinreich P; Nagy JI Neuroscience; 1986 Sep; 19(1):139-46. PubMed ID: 2431346 [TBL] [Abstract][Full Text] [Related]
19. Drug-induced alterations in neurotransmitter receptor binding and function. Enna SJ; Ferkany JW; Strong R Adv Biochem Psychopharmacol; 1980; 21():253-63. PubMed ID: 6246740 [No Abstract] [Full Text] [Related]
20. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum. Savasta M; Dubois A; Feuerstein C; Manier M; Scatton B Neurosci Lett; 1987 Feb; 74(2):180-6. PubMed ID: 2883609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]